DXGEN CORP.
- Shared products
- ALBUMIN, C-REACTIVE PROTEIN, GLYCATED HEMOGLOBIN (HbA1C), Instrument for analysis of general biochemistry, hormones, drugs or proteins
- Shared products
- ALBUMIN, C-REACTIVE PROTEIN, GLYCATED HEMOGLOBIN (HbA1C), Instrument for analysis of general biochemistry, hormones, drugs or proteins
- Shared products
- ALBUMIN, C-REACTIVE PROTEIN, GLYCATED HEMOGLOBIN (HbA1C), Instrument for analysis of general biochemistry, hormones, drugs or proteins
- Shared products
- ALBUMIN, C-REACTIVE PROTEIN, GLYCATED HEMOGLOBIN (HbA1C), Instrument for analysis of general biochemistry, hormones, drugs or proteins
- Shared products
- ALBUMIN, C-REACTIVE PROTEIN, GLYCATED HEMOGLOBIN (HbA1C), Instrument for analysis of general biochemistry, hormones, drugs or proteins
Explore comprehensive manufacturer profile for DXGEN CORP. based in South Korea through Pure Global AI's free Brazil medical device database. This manufacturer has 4 products registered with ANVISA across 4 unique technical categories. Their regulatory history spans from Jan 30, 2023 to May 02, 2023.
This page provides detailed insights including 4 recent product registrations including Instrument for analysis of general biochemistry, hormones, drugs or proteins, 4 most popular products with Instrument for analysis of general biochemistry, hormones, drugs or proteins having 1 registrations, 1 registration holders including CAPRICORN TECHNOLOGIES DO BRASIL LTDA, and 5 key competitors with ROCHE DIAGNOSTICS GMBH sharing 4 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.